# Rajangam Kanya: insider transactions

SEC CIK 1816676. Roles and transactions as reported on Form 4. Latest Form 4 filed 2026-10-23.

## Roles

| Company | Role | Transactions | First | Latest |
| --- | --- | ---: | --- | --- |
| [Senti Biosciences Holdings, Inc.](/companies/snti.md) | Pres. & Chief Med. & Dev. Off., Officer | 1 | 2026-10-21 | 2026-10-21 |

## Transactions: 1

Every transaction reported, newest first. Codes P and S are open-market purchases and sales. Reported price is as stated on the form.

| Date | Company | Transaction | Shares | Reported price | Value | Filing |
| --- | --- | --- | ---: | ---: | ---: | --- |
| 2026-10-21 | [Senti Biosciences Holdings, Inc.](/companies/snti.md) | Tax withholding (F) | 19,953 | $0.00 | $0 | [Form 4](/filings/0001628280-26-067085.md) |

Source: SEC EDGAR, Forms 4. Last ingested by Listed: Nov 1, 2026, 09:51 ET. No prices; not investment advice.